Inflammatory Arthritis in Clinical Practice
Description
There has been a revolution in treatments for inflammatory arthritis. Mostly, this is due to the introduction of biologics, particularly TNF inhibitors. These have changed approach to treatment in two ways. First, they appear substantially more effective than conventional drugs. Second, they are far more expensive than traditional treatment approaches. One consequence of this therapeutic revolution is a need to better understand arthritis and to place the new biological treatments into the context of existing management approaches.
Reviews / Votes
From the reviews: "A concise, up-to-date review of the pathogenesis, clinical features, and treatment of rheumatoid arthritis and spondyloarthropathies. ... it is aimed at family practitioners, rheumatology trainees, and related specialists, as well as allied health professionals in the field of rheumatology. Considering the clear and concise style of writing, the book would also be of benefit to medical students ... . For practicing rheumatologists, it is a good refresher ... . The straightforward, expert coverage makes it a great addition to the medical library ... ." (Vladimir N Despotovic, Doody's Review Service, July, 2008)More details
Other editions
New editions
Additional editions
Persons
David L Scott is Professor of Clinical Rheumatology at King's College School of Medicine, London, UK. He also leads the clinical service at King's College Hospital, London. His medical training was in Leeds, and he was introduced to rheumatology by working with Professor Verna Wright. He subsequently spent some years in Birmingham, completing research training for his MD with Professor Kenneth Walton and Professor Paul Bacon. He was an ARC and Wellcome Trust travelling fellow in the US and Europe and subsequently held the Muir Hambro Fellowship of the Royal College of Physicians. His research focuses on the treatment and outcome of arthritis, and he has written over 250 papers and been involved in 25 books in the field. He spent 5 years as editor of Rheumatology and is currently honorary Heberden Librarian at the British Society for Rheumatology. He is involved with many patient groups including Arthritis Care and the Arthritis and Musculoskeletal Alliance. He also serves on the Disability Living Allowance Advisory Board of the Department of Work and Pensions.